Black Diamond Therapeutics (BDTX) Executive & Key Data

Mark A. Velleca

Chief Executive Officer, President & Chairman

Compensation

$1,039,889

Brent Hatzis-Schoch

Chief Operating Officer & General Counsel

Compensation

$741,216

Elizabeth Buck

Co-Founder & Chief Scientific Officer

Compensation

$340,473

Erika Jones

Principal Financial Officer, Principal Accounting Officer, SVP of Finance & Corporate Controller

Compensation

Compensation not disclosed

Melanie Morrison

Chief Development Officer

Compensation

Compensation not disclosed

Sergey Yurasov

Chief Medical Officer

Compensation

$760,748

Black Diamond Therapeutics, Inc.